How much funding has Verge Genomics raised?

Verge Genomics has raised $176.1M in total funding, most recently a Corporate Round.

Who are Verge Genomics's investors?

Verge Genomics's investors include ALS Investment Fund, IA Ventures, Two Sigma Ventures, AstraZeneca, Merck Global Health Innovation Fund, Section 32.

When was Verge Genomics founded?

Verge Genomics was founded in 2015.

Where is Verge Genomics headquartered?

Verge Genomics is headquartered in South San Francisco.

What industry is Verge Genomics in?

Verge Genomics operates in Biotech, Drug Discovery, Healthcare.

How many employees does Verge Genomics have?

Verge Genomics has 11-50 employees.

Verge Genomics

We use human data and AI to develop better drugs faster.

South San Francisco · Founded 2015 · $176.1M raised

Biotech

Drug Discovery

Healthcare

YC S15

Headquarters: South San Francisco
Employees: 11–50
Founded: 2015
Business Model: B2B

Website: vergegenomics.com
Total Funding: $176.1M
Last Round: $42.0M Corporate RoundSep 2023
Rounds: 5

About

Verge uses artificial intelligence and human data to develop better drugs faster. Verge has an end-to-end technology-driven drug discovery and development platform, featuring one of the field’s largest and most comprehensive proprietary patient genomics datasets from human tissue. Verge uses machine learning to mine this data and develops these insights into new drugs using it’s human-centric biology and chemistry platforms.

Summary

Verge Genomics is a Biotech company based in South San Francisco, founded in 2015. It has raised $176.1M in total across 5 rounds, most recently a $42.0M Corporate Round round in Sep 2023. Investors include ALS Investment Fund, IA Ventures and Two Sigma Ventures.

LinkedIn X (Twitter)